Back
Biomarin Pharmaceutical Stock Price Chart
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
BMRN
Biomarin Pharmaceutical
Last Price:
68.17
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.81 | Sell |
| 20-day SMA: | 75.23 | Sell |
| 50-day SMA: | 83.07 | Sell |
| 200-day SMA: | 85.79 | Sell |
| 8-day EMA: | 70.62 | Sell |
| 20-day EMA: | 74.74 | Sell |
| 50-day EMA: | 79.97 | Sell |
| 200-day EMA: | 84.63 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.49 | Sell |
| Relative Strength Index (14 RSI): | 26.53 | Sell |
| Chaikin Money Flow: | 810420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.55 - 87.17) | Sell |
| Bollinger Bands (100): | (75.91 - 88.53) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 69.66 while BMRN 8-day simple moving average is 69.81, which is a Sell signal.
- The stock price of BMRN is 69.66 while Biomarin Pharmaceutical 20-day SMA is 75.23, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 83.07 while BMRN share price is 69.66, making it a Sell technically.
- BMRN stock price is 69.66 and Biomarin Pharmaceutical 200-day simple moving average is 85.79, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
31
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Sell
The current Biomarin Pharmaceutical [BMRN] share price is $69.66. The Score for BMRN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.26B
Price in USD:
69.66
Share Volume:
1.13M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
67.75
Sell
31
Biomarin Pharmaceutical (BMRN)
is a Sell
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 69.66 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 69.66 while BMRN 8-day exponential moving average is 70.62, which is a Sell signal.
- The stock price of BMRN is 69.66 while Biomarin Pharmaceutical 20-day EMA is 74.74, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 79.97 while BMRN share price is 69.66, making it a Sell technically.
- BMRN stock price is 69.66 and Biomarin Pharmaceutical 200-day simple moving average is 84.63, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -4.49, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 26.53, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (69.55 - 87.17), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (75.91 - 88.53), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.